Few companies have been able to fundamentally change their operating and business models around AI. The primary obstacle to ...
For years, the guiding assumption of artificial intelligence has been simple: an AI is only as good as the data it has seen. Feed it more, train it longer, and it performs better. Feed it less, and it ...
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...